---
title: "Guanfacine - Attention Deficit Hyperactivity Disorder"
sidebar: mydoc_sidebar
permalink: db01018-mesh-d001289-1.html
toc: false 
---


Path ID: `DB01018_MESH_D001289_1`
{% include image.html url="images/db01018-mesh-d001289-1.png" file="db01018-mesh-d001289-1.png" alt="db01018-mesh-d001289-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D016316">MESH:D016316 </a> | Guanfacine | Drug |
| <a href="https://identifiers.org/UniProt:P08913">UniProt:P08913 </a> | Alpha-2A adrenergic receptor | Protein |
| <a href="https://identifiers.org/MESH:D001289">MESH:D001289 </a> | Attention deficit hyperactivity disorder | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Guanfacine | INCREASES ACTIVITY OF | Alpha-2A Adrenergic Receptor |
| Alpha-2A Adrenergic Receptor | TREATS | Attention Deficit Hyperactivity Disorder |
|---------|-----------|---------|

Comment: The link between guanfacine’s molecular mechanism and it’s effect on the treatment of ADHD has not been determined

Reference: 
  - [https://go.drugbank.com/drugs/DB01018](https://go.drugbank.com/drugs/DB01018)
